[Vitamin B12 deficiency secondary to metformin therapy].
Esteban Jiménez
Oscar
O
González Rubio
Francisca
F
Buñuel Granados
José Miguel
JM
Navarro Pemán
Cristina
C
D000368:Aged; D000740:Anemia / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004357:Drug Synergism; D005260:Female; D005492:Folic Acid / Q000378:metabolism; D006801:Humans; D020138:Hyperhomocysteinemia / Q000209:etiology; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D007408:Intestinal Absorption; D008297:Male; D008687:Metformin / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D054328:Proton Pump Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D012189:Retrospective Studies; D014805:Vitamin B 12 / Q000493:pharmacokinetics / Q000627:therapeutic use; D014806:Vitamin B 12 Deficiency / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control
D007004:Hypoglycemic Agents; D054328:Proton Pump Inhibitors; D008687:Metformin; D005492:Folic Acid; D014805:Vitamin B 12